Syngene International Limited has filed its mandatory compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026. The pharmaceutical contract research and manufacturing services company submitted the certificate to both BSE and NSE on April 08, 2026.

Regulatory Compliance Filing

The company's filing confirms that all securities dematerialization details for Q4FY26 have been properly furnished to stock exchanges where Syngene International shares are listed. The certificate was signed by Company Secretary & Compliance Officer Chethan Yogesh.

RTA Confirmation Certificate

KFin Technologies Limited, serving as the company's Registrar and Transfer Agent (RTA), provided confirmation on April 06, 2026. The RTA certified that during the January-March 2026 period, all dematerialization processes were handled in compliance with regulatory requirements.

Regulatory Framework

Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 mandates companies to ensure proper handling of dematerialization requests and maintain accurate records. The regulation requires confirmation that securities comprised in certificates have been listed on appropriate stock exchanges and that proper verification procedures are followed before certificate cancellation.

The filing demonstrates Syngene International's adherence to regulatory compliance requirements and maintains transparency with market participants regarding its share dematerialization processes during the quarter.

Syngene International Limited has received a significant favorable outcome in its ongoing tax litigation matters, securing a refund of ₹43.15 crores including interest for Assessment Year 2016-17. The biotechnology services company disclosed this development to stock exchanges following receipt of an order from tax authorities.

Tax Order Details and Timeline

The company received an order which gives effect to decisions made by the National Faceless Appeal Centre (NFAC) for Assessment Year 2016-17. This order was communicated to Syngene from the Deputy Commissioner of Income-tax, Circle 6(1)(1), Bangalore.

Background of Tax Litigation

The tax matter has a complex history spanning multiple assessment years. Initially, the Assessing Officer had passed an order under Section 143(3) making certain disallowances and additions, resulting in a demand of ₹72.34 crores. Syngene filed an appeal against these disallowances and additions.

The company also filed a Writ Petition before the Karnataka High Court regarding the adjustment of refunds granted for Assessment Years 2010-11 and 2011-12 against outstanding demands for other years, along with the non-issue of refund for AY 2012-13, aggregating to ₹48.91 crores.

Court Orders and Resolution Process

Syngene has provided updates on recent developments in this matter. The Karnataka High Court allowed the company's Writ Petition, while the NFAC partially allowed the company's appeal for AY 2016-17. Out of the total amount of ₹48.91 crores involved in the writ petition, ₹22.70 crores had been adjusted to AY 2016-17.

Financial Impact and Company Position

Syngene believes there will be no material impact on the company's financials, operations, or activities due to this development. The company expects a decrease in contingent liability related to Assessment Year 2016-17. The refund amount of ₹43.15 crores is yet to be received by the company.

The current order imposes no penalty, restrictions, or sanctions. The company stated it is analyzing the order and will take appropriate action as needed. This resolution represents a positive outcome for Syngene International in its ongoing tax litigation matters, providing clarity on a significant portion of its tax disputes.